Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $8.86 in the prior trading day, Design Therapeutics Inc (NASDAQ: DSGN) closed at $9.01, up 1.69%. In other words, the price has increased by $1.69 from its previous closing price. On the day, 2.44 million shares were traded. DSGN stock price reached its highest trading level at $9.43 during the session, while it also had its lowest trading level at $8.795.
Ratios:
Our goal is to gain a better understanding of DSGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.71 and its Current Ratio is at 18.71. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 03, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on November 20, 2025, while the target price for the stock was maintained at $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’25 when Logos Global Master Fund LP bought 120,000 shares for $7.43 per share.
Logos Global Master Fund LP bought 620,000 shares of DSGN for $4,377,200 on Nov 14 ’25. On Nov 07 ’25, another insider, Logos Global Master Fund LP, who serves as the Director of the company, bought 415,000 shares for $6.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 513243456 and an Enterprise Value of 309016448.
Stock Price History:
The Beta on a monthly basis for DSGN is 1.64, which has changed by 0.41760004 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, DSGN has reached a high of $10.31, while it has fallen to a 52-week low of $2.60. The 50-Day Moving Average of the stock is 17.06%, while the 200-Day Moving Average is calculated to be 69.92%.
Shares Statistics:
The stock has traded on average 306.54K shares per day over the past 3-months and 264910 shares per day over the last 10 days, according to various share statistics. A total of 56.96M shares are outstanding, with a floating share count of 31.27M. Insiders hold about 45.10% of the company’s shares, while institutions hold 42.73% stake in the company. Shares short for DSGN as of 1764288000 were 2105995 with a Short Ratio of 6.87, compared to 1761868800 on 1849031. Therefore, it implies a Short% of Shares Outstanding of 2105995 and a Short% of Float of 5.59.
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.31 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$1.25 and -$1.31 for the fiscal current year, implying an average EPS of -$1.28. EPS for the following year is -$1.31, with 4.0 analysts recommending between -$0.98 and -$1.55.
